bezafibrate has been researched along with Breast Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MH; Osman, KA | 1 |
| Enzan, H; Ogawa, Y; Onishi, S; Saibara, T; Yoshida, S | 1 |
| Hamada, N; Inomata, T; Kariya, S; Murata, Y; Nishioka, A; Ogawa, Y; Saibara, T; Terashima, M; Yoshida, S | 1 |
| Holman, NA; Lee, WJ; May, FJ; Roberts-Thomson, SJ; Suchanek, KM | 1 |
| Akisawa, N; Iwasaki, S; Maeda, T; Nemoto, Y; Ogawa, Y; Onishi, S; Ono, M; Saibara, T; Xu, N; Zhang, T | 1 |
5 other study(ies) available for bezafibrate and Breast Cancer
| Article | Year |
|---|---|
Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist.
Topics: Antineoplastic Agents, Hormonal; Bezafibrate; Breast Neoplasms; Diabetes Complications; Disease Progression; Fatty Liver; Humans; Hypolipidemic Agents; Prognosis; Tamoxifen; Time Factors | 2006 |
Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
Topics: Antineoplastic Agents, Hormonal; Bezafibrate; Breast Neoplasms; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis; Tamoxifen | 1999 |
Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Topics: Alanine Transaminase; Alcohol Drinking; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bezafibrate; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Cholesterol; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogen Receptor Modulators; Fatty Liver; Female; Fluorouracil; Humans; Mastectomy, Segmental; Middle Aged; Radiotherapy, Adjuvant; Tamoxifen; Tomography, X-Ray Computed; Toremifene | 2000 |
Peroxisome proliferator-activated receptor beta expression in human breast epithelial cell lines of tumorigenic and non-tumorigenic origin.
Topics: Bezafibrate; Breast Neoplasms; Cell Line; Culture Media, Serum-Free; DNA-Binding Proteins; Epithelial Cells; Humans; Hypolipidemic Agents; Nuclear Proteins; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Ribosomal, 18S; Transcription Factors | 2002 |
Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen.
Topics: Adult; Antineoplastic Agents, Hormonal; Bezafibrate; Breast Neoplasms; Chemical and Drug Induced Liver Injury, Chronic; Estradiol; Fatty Liver; Female; Humans; Hypolipidemic Agents; Tamoxifen; Tomography, X-Ray Computed | 2002 |